Watchtower/Law library/Money Laundering, Terrorist.../2 Modifications: Control over...
As last captured

Money Laundering, Terrorist Financing and Transfer of Funds... · Schedule 6B

2 Modifications: Control over registered cryptoasset businesses registered before 25th October 2027

Sch. 6B para. 2 · in force: yes

Captured statutory text (L5)

2 Modifications: Control over registered cryptoasset businesses registered before 25th October 2027

The modifications specified in this paragraph are—
(a)references to a “UK authorised person” are to be read as references to a registered cryptoasset business;
(b)references to “appropriate regulator” and “each regulator” are to be read as references to the FCA;
(c)section 178 (obligation to notify the appropriate regulator: acquisitions of control) is to be read as if subsections (2ZA) and (2A) were omitted;
(d)section 181 (acquiring control) is to be read as if it said— Acquiring control(181)
(1)For the purposes of this Part, a person (“A”) acquires control over a registered cryptoasset business (“B”) if, should the acquisition proceed—
(a)A would become a beneficial owner within the meaning of regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—
(i)B; or
(ii)a parent undertaking of B (“P”); or
(b)if paragraph (a) does not apply A would—
(i)hold 10% or more of the shares in B or P;
(ii)hold 10% or more of the voting power in B or P; or
(iii)otherwise hold shares or voting power in B or P as a result of which A is able to exercise significant influence over the management of B.
;
(e)section 182 (increasing control) is to be read as if it said— Increasing control(182)
(1)For the purposes of this Part, a person (“A”) increases control over a registered cryptoasset business (“B”) if, should the increase in control proceed—
(a)A would become a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—
(i)B; or
(ii)a parent undertaking of B (“P”); or
(b)if paragraph (a) does not apply—
(i)the percentage of shares which A holds in B or P would increase by any of the steps mentioned in subsection (2);
(ii)the percentage of voting power A holds in B or P would increase by any of the steps mentioned in subsection (2); or
(iii)A becomes a parent undertaking of B.
(2)The steps are—
(a)from less than 20% to 20% or more;
(b)from less than 30% to 30% or more;
(c)from less than 50% to 50% or more.
;
(f)section 183 (reducing or ceasing to have control) is to be read as if it said— Reducing or ceasing to have control(183)
(1)For the purposes of this Part, a person (“A”) reduces control over a registered cryptoasset business (“B”) if, should the decrease in control proceed—
(a)A would cease to be a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—
(i)B; or
(ii)a parent undertaking of B (“P”); or
(b)if paragraph (a) does not apply—
(i)the percentage of shares which A holds in B or P would decrease by any of the steps mentioned in subsection (2);
(ii)the percentage of voting power A holds in B or P would decrease by any of the steps mentioned in subsection (2); or
(iii)A ceases to be a parent undertaking of B.
(2)The steps are—
(a)from 50% or more to less than 50%;
(b)from 30% or more to less than 30%;
(c)from 20% or more to less than 20%.
(3)For the purposes of this Part, A ceases to have control over B if—
(a)A ceases to be a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of B or P; or
(b)if paragraph (a) does not apply, A ceases to be in the position of holding—
(i)10% or more of the shares in B;
(ii)10% or more of the voting power in B or P; or
(iii)shares or voting power in B or P as a result of which A is able to exercise significant influence over the management of B.
;
(g)section 184 (disregarded holdings) is to be read as if subsections (4) to (10) were omitted;
(h)section 185 (assessment: general) is to be read as if—
(i)in subsection (2)(a), “and the financial soundness of the acquisition” were omitted;
(ii)in subsection (3)(a), in relation to a section 178 notice-giver who falls within section 181(a) or 182(1)(a), for “matters” there were substituted “matter”;
(i)section 186 (assessment criteria) is to be read in relation to a section 178 notice-giver who falls within section 181(a) or 182(1)(a) as if it said— Assessment criterion(186) The matter specified in section 185(3)(a) is whether the section 178 notice-giver is a fit and proper person within the meaning of regulation 58A of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (fit and proper test: cryptoasset businesses). ;
(j)section 187 (approval with conditions) is to be read as if subsection (2)(b) were omitted;
(k)section 187A (assessment: consultation by PRA with FCA) is to be disregarded;
(l)section 187B (assessment: consultation by FCA with PRA) is to be disregarded;
(m)section 187C (variation etc of conditions) is to be disregarded;
(n)section 189 (assessment: procedure) is to be read as if—
(i)subsections (1A), (1ZB) and (1B) were omitted;
(ii)in subsection (6), “Unless section 190A applies” were omitted;
(o)section 190 (requests for further information) is to be read as if subsections (1A) and (4)(b) were omitted;
(p)section 190A (assessment and resolution) is to be disregarded;
(q)section 191A (objection by the appropriate regulator) is to be read as if—
(i)in subsection (2)(c), for “matters in” there were substituted “matter specified in”;
(ii)subsection (4A) were omitted;
(r)section 191B (restriction notices) is to be read as if—
(i)in subsection (2)(a), after “voting power” there were inserted “or otherwise being a beneficial owner (within the meaning of regulations 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017) of the registered cryptoasset business (“B”) or a parent undertaking of B”;
(ii)in subsection (2)(b), “in relation to the shares or voting power,” were omitted;
(iii)subsection (2A) were omitted;
(iv)after subsection (3) there were inserted—
(3ZA)In a restriction notice, the FCA may direct that, in respect of a beneficial owner of B or P, until further notice, no influence over the management or activities of B is to be exercisable by the beneficial owner.
;
(v)subsection (3A) were omitted;
(vi)in subsection (6)(b), after “held in” there were inserted “, or beneficial ownership of,”;
(s)section 191C (orders for sale of shares) is to be read as if—
(i)subsections (2A), (7) and (8) were omitted;
(ii)in subsection (2B) for “Where the appropriate regulator is the FCA, it” there were substituted “The FCA”;
(t)section 191D (obligation to notify the appropriate regulator: dispositions of control) is to be read as if subsection (1A) were omitted;
(u)section 191F (offences under this Part) is to be read as if—
(i)in subsection (2), “or section 190A applies” were omitted;
(ii)subsection (4A) were omitted;
(iii)for subsections (8) and (9) there were substituted—
(8)A person guilty of an offence under subsection (1) to (3) or (5) to (7) is liable—
(a)on summary conviction—
(i)in England and Wales, to a fine;
(ii)in Scotland or Northern Ireland, to a fine not exceeding the statutory minimum;
(b)on conviction on indictment, to a fine.
(9)A person guilty of an offence under subsection (4) is liable—
(a)on summary conviction—
(i)in England and Wales, to a fine;
(ii)in Scotland and Northern Ireland, to a fine not exceeding the statutory minimum;
(b)on conviction on indictment, to imprisonment for a term not exceeding two years or a fine, or both.
;
(iv)after subsection (9) there were inserted—
(10)A person is not guilty of an offence under this section if that person took all reasonable steps and exercised all due diligence to avoid committing the offence.
;
(v)section 191G (interpretation) is to be read—
(i)as if the definitions of “the appropriate regulator”, “qualifying credit institution” and “UK authorised person” were omitted;
(ii)at the appropriate places there were inserted— “registered cryptoasset business” means a cryptoasset exchange provider or a custodian wallet provider which is included in the register maintained by the FCA under regulation 54(1A) of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017. .
Full captured verbatim text
The modifications specified in this paragraph are—

(a) references to a “UK authorised person” are to be read as references to a registered cryptoasset business;

(b) references to “appropriate regulator” and “each regulator” are to be read as references to the FCA;

(c) section 178 (obligation to notify the appropriate regulator: acquisitions of control) is to be read as if subsections (2ZA) and (2A) were omitted;

(d) section 181 (acquiring control) is to be read as if it said—

Acquiring control(181) (1) For the purposes of this Part, a person (“A”) acquires control over a registered cryptoasset business (“B”) if, should the acquisition proceed—

(a) A would become a beneficial owner within the meaning of regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—

(i) B; or

(ii) a parent undertaking of B (“P”); or

(b) if paragraph (a) does not apply A would—

(i) hold 10% or more of the shares in B or P;

(ii) hold 10% or more of the voting power in B or P; or

(iii) otherwise hold shares or voting power in B or P as a result of which A is able to exercise significant influence over the management of B.

;

(e) section 182 (increasing control) is to be read as if it said—

Increasing control(182) (1) For the purposes of this Part, a person (“A”) increases control over a registered cryptoasset business (“B”) if, should the increase in control proceed—

(a) A would become a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—

(i) B; or

(ii) a parent undertaking of B (“P”); or

(b) if paragraph (a) does not apply—

(i) the percentage of shares which A holds in B or P would increase by any of the steps mentioned in subsection (2);

(ii) the percentage of voting power A holds in B or P would increase by any of the steps mentioned in subsection (2); or

(iii) A becomes a parent undertaking of B.

(2) The steps are—

(a) from less than 20% to 20% or more;

(b) from less than 30% to 30% or more;

(c) from less than 50% to 50% or more.

;

(f) section 183 (reducing or ceasing to have control) is to be read as if it said—

Reducing or ceasing to have control(183) (1) For the purposes of this Part, a person (“A”) reduces control over a registered cryptoasset business (“B”) if, should the decrease in control proceed—

(a) A would cease to be a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of—

(i) B; or

(ii) a parent undertaking of B (“P”); or

(b) if paragraph (a) does not apply—

(i) the percentage of shares which A holds in B or P would decrease by any of the steps mentioned in subsection (2);

(ii) the percentage of voting power A holds in B or P would decrease by any of the steps mentioned in subsection (2); or

(iii) A ceases to be a parent undertaking of B.

(2) The steps are—

(a) from 50% or more to less than 50%;

(b) from 30% or more to less than 30%;

(c) from 20% or more to less than 20%.

(3) For the purposes of this Part, A ceases to have control over B if—

(a) A ceases to be a beneficial owner within the meaning given by regulation 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 of B or P; or

(b) if paragraph (a) does not apply, A ceases to be in the position of holding—

(i) 10% or more of the shares in B;

(ii) 10% or more of the voting power in B or P; or

(iii) shares or voting power in B or P as a result of which A is able to exercise significant influence over the management of B.

;

(g) section 184 (disregarded holdings) is to be read as if subsections (4) to (10) were omitted;

(h) section 185 (assessment: general) is to be read as if—

(i) in subsection (2)(a), “and the financial soundness of the acquisition” were omitted;

(ii) in subsection (3)(a), in relation to a section 178 notice-giver who falls within section 181(a) or 182(1)(a), for “matters” there were substituted “matter”;

(i) section 186 (assessment criteria) is to be read in relation to a section 178 notice-giver who falls within section 181(a) or 182(1)(a) as if it said—

Assessment criterion(186) The matter specified in section 185(3)(a) is whether the section 178 notice-giver is a fit and proper person within the meaning of regulation 58A of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (fit and proper test: cryptoasset businesses).

;

(j) section 187 (approval with conditions) is to be read as if subsection (2)(b) were omitted;

(k) section 187A (assessment: consultation by PRA with FCA) is to be disregarded;

(l) section 187B (assessment: consultation by FCA with PRA) is to be disregarded;

(m) section 187C (variation etc of conditions) is to be disregarded;

(n) section 189 (assessment: procedure) is to be read as if—

(i) subsections (1A), (1ZB) and (1B) were omitted;

(ii) in subsection (6), “Unless section 190A applies” were omitted;

(o) section 190 (requests for further information) is to be read as if subsections (1A) and (4)(b) were omitted;

(p) section 190A (assessment and resolution) is to be disregarded;

(q) section 191A (objection by the appropriate regulator) is to be read as if—

(i) in subsection (2)(c), for “matters in” there were substituted “matter specified in”;

(ii) subsection (4A) were omitted;

(r) section 191B (restriction notices) is to be read as if—

(i) in subsection (2)(a), after “voting power” there were inserted “or otherwise being a beneficial owner (within the meaning of regulations 5 or 6 of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017) of the registered cryptoasset business (“B”) or a parent undertaking of B”;

(ii) in subsection (2)(b), “in relation to the shares or voting power,” were omitted;

(iii) subsection (2A) were omitted;

(iv) after subsection (3) there were inserted—

(3ZA) In a restriction notice, the FCA may direct that, in respect of a beneficial owner of B or P, until further notice, no influence over the management or activities of B is to be exercisable by the beneficial owner.

;

(v) subsection (3A) were omitted;

(vi) in subsection (6)(b), after “held in” there were inserted “, or beneficial ownership of,”;

(s) section 191C (orders for sale of shares) is to be read as if—

(i) subsections (2A), (7) and (8) were omitted;

(ii) in subsection (2B) for “Where the appropriate regulator is the FCA, it” there were substituted “The FCA”;

(t) section 191D (obligation to notify the appropriate regulator: dispositions of control) is to be read as if subsection (1A) were omitted;

(u) section 191F (offences under this Part) is to be read as if—

(i) in subsection (2), “or section 190A applies” were omitted;

(ii) subsection (4A) were omitted;

(iii) for subsections (8) and (9) there were substituted—

(8) A person guilty of an offence under subsection (1) to (3) or (5) to (7) is liable—

(a) on summary conviction—

(i) in England and Wales, to a fine;

(ii) in Scotland or Northern Ireland, to a fine not exceeding the statutory minimum;

(b) on conviction on indictment, to a fine.

(9) A person guilty of an offence under subsection (4) is liable—

(a) on summary conviction—

(i) in England and Wales, to a fine;

(ii) in Scotland and Northern Ireland, to a fine not exceeding the statutory minimum;

(b) on conviction on indictment, to imprisonment for a term not exceeding two years or a fine, or both.

;

(iv) after subsection (9) there were inserted—

(10) A person is not guilty of an offence under this section if that person took all reasonable steps and exercised all due diligence to avoid committing the offence.

;

(v) section 191G (interpretation) is to be read—

(i) as if the definitions of “the appropriate regulator”, “qualifying credit institution” and “UK authorised person” were omitted;

(ii) at the appropriate places there were inserted—

“registered cryptoasset business” means a cryptoasset exchange provider or a custodian wallet provider which is included in the register maintained by the FCA under regulation 54(1A) of the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017.

.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: failed · Stored artifact; current recipe verification unavailable

L3 unavailable: no verified one-line summary for this provision.

No verified summary for this provision yet; read the text itself.

Refers to

cross-reference internal_cite · reg. 5

cross-reference internal_cite · reg. 54

cross-reference internal_cite · reg. 58A

cross-reference internal_cite · reg. 6

Referred to by

schedule ref schedule_ref · reg. 59

schedule ref schedule_ref · reg. 60B

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (348)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-6

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-7

synthesis coverage: missing/unverified L2 part-2-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-9

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-10

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-12

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-13

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-14A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-15

synthesis coverage: missing/unverified L2 part-2-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-16A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-17

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-18A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-19A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-20

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-21

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-22

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-23

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-24

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-25

synthesis coverage: missing/unverified L2 part-2-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-26

synthesis coverage: missing/unverified L2 part-3-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-27

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-28

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-29

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-30A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-31

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-32

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-33

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-34

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-35

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-36

synthesis coverage: missing/unverified L2 part-3-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-37

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-38

synthesis coverage: missing/unverified L2 part-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-39

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-40

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-41

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-42

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-43

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-44

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZA

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45ZB

synthesis coverage: missing/unverified L2 part-5A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45F

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45G

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-45H

synthesis coverage: missing/unverified L2 part-6-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-46A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-47

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-48

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-49

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-50

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-51

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-52B

synthesis coverage: missing/unverified L2 part-6-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-53

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-54

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-55

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-56B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-57

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-58A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-59

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60

synthesis coverage: missing/unverified L2 part-6-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-60B

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-61

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-62

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-63

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64

synthesis coverage: missing/unverified L2 part-7A-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64B

synthesis coverage: missing/unverified L2 part-7A-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64C

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64D

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64E

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64F

synthesis coverage: missing/unverified L2 part-7A-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64G

synthesis coverage: missing/unverified L2 part-7A-chapter-4

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-64H

synthesis coverage: missing/unverified L2 part-8

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-65

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-66

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-67

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-68

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-69

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-70

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-71

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-72

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-73

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74B

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-74C

synthesis coverage: missing/unverified L2 part-9-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-75

synthesis coverage: missing/unverified L2 part-9-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-76

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-77

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-78

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-79

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-80

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-81

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-82

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-83

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-84

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-85

synthesis coverage: missing/unverified L2 part-9-chapter-3

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-86

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-87

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-88

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-89

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-90

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-91

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-92

synthesis coverage: missing/unverified L2 part-10-chapter-1

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-93

synthesis coverage: missing/unverified L2 part-10-chapter-2

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-94

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-95

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-96

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-97

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-98

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-99

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-100

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-101

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-102

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-103

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-104A

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-105

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-106

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-107

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-108

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-109

synthesis coverage: missing evaluation uk:uksi/2017/692#regulation-110

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-27A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-29

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3-paragraph-35

synthesis coverage: missing/unverified L2 schedule-3AZA

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3AZA-paragraph-3

synthesis coverage: missing/unverified L2 schedule-3A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-1A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-8A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-9B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-23A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-3A-paragraph-24

synthesis coverage: missing/unverified L2 schedule-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-12A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-15A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-4-paragraph-19

synthesis coverage: missing/unverified L2 schedule-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-5-paragraph-4

synthesis coverage: missing/unverified L2 schedule-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-11A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6-paragraph-13

synthesis coverage: missing/unverified L2 schedule-6A

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6A-paragraph-16

synthesis coverage: missing/unverified L2 schedule-6B

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-6B-paragraph-5

synthesis coverage: missing/unverified L2 schedule-7-part-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-11

synthesis coverage: missing/unverified L2 schedule-7-part-2

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2017/692#schedule-7-paragraph-35

Instrument tier unavailable

Change history as published

Reg. 22 omitted (31.12.2020) by virtue of The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/253), regs. 1(2), 5(4) (with savings in S.I. 2019/680, reg. 11); 2020 c. 1, Sch. 5 para. 1(1)

Pt. 5A omitted (1.9.2022) by virtue of The Money Laundering and Terrorist Financing (Amendment) (No. 2) Regulations 2022 (S.I. 2022/860), regs. 1(5), 10 · repeated 8×

Sch. 7 para. 27 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

reg. 3(1) words inserted by The Money Laundering and Transfer of Funds (Information) (Amendment) (EU Exit) Regulations 2019 reg. 3(b) · Effective date unknown · reg. 3

reg. 34A inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 20 · Effective date unknown

Sch. 6 para. 7(ga) inserted by The Money Laundering and Terrorist Financing (Amendment) Regulations 2026 reg. 36(b) · Effective date unknown · Sch. 6 para. 7

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument
uk:uksi/2017/692
Part
Schedule 6B
Version
c5a0271554697d8359bede8a…
Content hash
sha256 48627cdfacd11e4cc97aaf0c…
Source
legislation.gov.uk/uksi/2017/692